Equities analysts expect Sarepta Therapeutics Inc (NASDAQ:SRPT) to announce $97.47 million in sales for the current fiscal quarter, according to Zacks. Eight analysts have issued estimates for Sarepta Therapeutics’ earnings, with estimates ranging from $95.00 million to $100.70 million. Sarepta Therapeutics posted sales of $78.49 million in the same quarter last year, which would indicate […]